(Traveling to Asia, South East Asia, Indian Subcontinent, Western Pacific and Northern Part of Australia)
Japanese Encephalitis is a viral infection transmitted by the bite of infected mosquitoes, contracted the mortality rate of this disease is very high, as this disease is mainly zoonosis prevalent for people who intend to work in the farms and with the animals, or traveling for long duration for business or extended travel are strongly advised to have this vaccination. As this vaccination requires a series of two injections, plan early for this before your departure.
Japanese Encephalitis Information
Japanese encephalitis (JE) virus is the leading cause of vaccine-preventable encephalitis in Asia and the western Pacific. For most travelers to Asia, the risk for JE is very low but varies based on destination, duration of travel, season, and activities. JE virus is maintained in a cycle involving mosquitoes and vertebrate hosts, mainly pigs and wading birds. Humans may be infected when bitten by an infected mosquito.
Most human infections are asymptomatic or result in mild symptoms. However, a small percentage of infected persons develop inflammation of the brain (encephalitis), with symptoms including sudden onset of headache, high fever, disorientation, coma, tremors and convulsions.
About 1 in 4 cases are fatal. Nno specific treatment exists for JE. Patient management focuses on supportive care and management of complications. Steps to prevent JE include using personal protective measures to prevent mosquito bites and vaccination.
Two types of Japanese Encephalitis vaccination are available
Inactivated vaccination- Jespect
- Marketed in Australia as Jespect is course of two injection 0 and 28 days apart
- Live Vaccination
- Single Vaccination
- Duration of vaccines vary
New vaccination. Single vaccination based on the Yellow Fever vaccination formula. Single vaccination covers minimum 4 to 5 years as current statistics available
Since it is live vaccination some restrictions and side effects should be kept in before administering the vaccine under taken. Client’s medical condition should be evaluated properly prior